scholarly journals A CASE OF MAMMARY GLAND GLYCOGEN-RICH CLEAR CELL CARCINOMA ASSOCIATED WITH SUBACUTE NECROTIZING LYMPHADENITIS REQUIRING DISTINCTION FROM LYMPH NODE METASTASIS

2011 ◽  
Vol 72 (4) ◽  
pp. 857-862
Author(s):  
Fumihiko SATOH ◽  
Minoru OKAZAKI ◽  
Akira OKAZAKI ◽  
Yoshiki WATANABE ◽  
Eimei NARIMATSU
Keyword(s):  
Mammary Gland ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cell Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Node Metastasis ◽  
Necrotizing Lymphadenitis

Hyalinizing Clear Cell Carcinoma of Salivary Origin

1994 ◽  
Vol 103 (9) ◽  
pp. 746-748 ◽  
Author(s):  
John G. Batsakis ◽  
Adel K. El-Naggar ◽  
Mario A. Luna
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cell Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Regional Lymph Node ◽  
Locoregional Control ◽  
Hyalinizing Clear Cell Carcinoma ◽  
Node Metastasis ◽  
Base Of Tongue

The recently described hyalinizing clear cell carcinoma of salivary tissues joins other clinicopathologic entities in its segregation from the formerly nondescript and heterogeneous classification “clear cell neoplasms.” The carcinoma is preponderantly an intraoral (palate and base of tongue) neoplasm that is always infiltrative and capable of regional lymph node metastasis. To date, it has responded to locoregional control treatments and has not been life-consuming.

scholarly journals The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry

2015 ◽  
Vol 26 (1) ◽  
pp. 19 ◽  
Author(s):  
Malcolm D. Mattes ◽  
Jennifer C. Lee ◽  
Daniel J. Metzger ◽  
Hani Ashamalla ◽  
Evangelia Katsoulakis
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cell Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Node Metastasis ◽  
Aortic Lymph Node

Prevalence of lymph node metastasis and role of lymphadenectomy for apparent early-stage ovarian clear cell carcinoma

2021 ◽  
Vol 162 ◽  
pp. S244
Author(s):  
Dimitrios Nasioudis ◽  
Stefan Gysler ◽  
Nawar Latif ◽  
Ashley Haggerty ◽  
Lori Cory ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cell Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Early Stage ◽  
Ovarian Clear Cell Carcinoma ◽  
Node Metastasis

Incidence of lymph node metastasis in comprehensively staged clear cell carcinoma grossly confined to the ovary

2014 ◽  
Vol 133 ◽  
pp. 88
Author(s):  
J.J. Mueller ◽  
C.H. Han ◽  
K. Santos ◽  
S. Wethington ◽  
S.Z. Dejbakhsh ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cell Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Node Metastasis

Prevalence and Prognostic Impact of Lymphadenectomy and Lymph Node Metastasis in Clinically Early-Stage Ovarian Clear Cell Carcinoma

2013 ◽  
Vol 23 (7) ◽  
pp. 1226-1230 ◽  
Author(s):  
Haider Mahdi ◽  
Mehdi Moslemi-Kebria ◽  
Kimberly L. Levinson ◽  
Anar Gojayev ◽  
David Lockhart ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Prognostic Impact ◽  
Disease Specific Survival ◽  
Ovarian Clear Cell Carcinoma ◽  
Extensive Lymphadenectomy ◽  
Node Metastasis ◽  
Disease Specific

ObjectivesThe objective of this study was to estimate the prevalence and prognostic impact of lymphadenectomy and lymph node involvement in patients with ovarian clear cell carcinoma (OCCC) grossly confined to the ovary.MethodsPatients with a diagnosis of OCCC grossly confined to the ovary were identified from Surveillance, Epidemiology, and End Results program from 1988 to 2007. Only surgically treated patients were included. Statistical analysis using Studentttest, Kaplan-Meier survival methods, and Cox proportional hazards regression were performed.ResultsOne thousand eight hundred ninety-seven patients with OCCC who have undergone surgical treatment and deemed at time of the surgery to have disease grossly confined to the ovary were included: 538 (28.3%) had no lymphadenectomy (LND −1), and 1359 (71.7%) had lymphadenectomy. Of the 1359 patients who had lymphadenectomy, 1298 (95.5%) were International Federation of Gynecology and Obstetrics (FIGO) surgical stage I (LND +1), and 61 (4.5%) were upstaged to FIGO stage IIIC due to nodal metastasis (LND +3C). The 5-year disease-specific survival was 84.9% for LND −1, 88.0% for LND +1, and 65.0% for LND +3C (P< 0.001). Among those with histologically negative lymph nodes, the 5-year disease-specific survival was 85% for patients with 1 to 10 nodes removed, and 91% for those with more than 10 nodes removed (P= 0.054). On multivariate analysis after controlling for stage, age, and race, lymph node metastasis was an independent predictor of poor disease-specific survival (hazard ratio, 3.1; 95% confidence interval, 1.86–5.28;P< 0.001). On other hand, there was a trend toward an improved survival when more extensive lymphadenectomy is performed in patients with histologically negative nodes (1–10 vs >10 nodes), but it did not reach statistical significance (hazard ratio, 0.71; 95% confidence interval, 0.49–1.02;P= 0.064).ConclusionsLymph node metastasis was uncommon in patients diagnosed with OCCC grossly confined to the ovary; however, patients with positive nodes were more likely to die compared to those with negative nodes. More extensive lymphadenectomy plays an important role in providing accurate staging and prognostic information.

Sign in / Sign up

Export Citation Format

Share Document